@article {Antovice000197, author = {Aleksandra Antovic and Maria Sennstr{\"o}m and Katarina Bremme and Elisabet Svenungsson}, title = {Obstetric antiphospholipid syndrome}, volume = {5}, number = {1}, elocation-id = {e000197}, year = {2018}, doi = {10.1136/lupus-2016-000197}, publisher = {Archives of Disease in childhood}, abstract = {The present clinical and laboratory classification criteria for antiphospholipid syndrome (APS) were established in Sydney, Australia, in 2006. In this review, we focus on the obstetric subset of APS (OAPS), defined by persistent positivity for antiphospholipid antibodies together with either early recurrent pregnancy loss, early fetal death, stillbirth or premature birth \<34 gestational weeks due to pre-eclampsia, eclampsia and placental insufficiency. It is important to diagnose these cases since most women suffering from OAPS can, when given appropriate treatment, have successful pregnancies. Furthermore, patients with OAPS may, depending on the antibody profile, be at enhanced risk of thrombotic events later in life. We present an update on the present knowledge of possible underlying pathogenesis, risk factors and risk estimations for adverse pregnancy outcomes before and during pregnancy, current treatment concepts, and long-term outcomes for women with OAPS and their children.}, URL = {https://lupus.bmj.com/content/5/1/e000197}, eprint = {https://lupus.bmj.com/content/5/1/e000197.full.pdf}, journal = {Lupus Science \& Medicine} }